Gastroesophageal Reflux Disease (GERD) 
The MD Magazine Gastroesophageal Reflux Disease (GERD) condition center provides clinical news and articles, information about upcoming conferences and meetings, updated clinical trial listings, and other resources.

Latest Headlines

Newly Approved GERD Drug Melts in Your Mouth
The US Food and Drug Administration (FDA) has approved dexlansoprazole (Dexilant SoluTab/Takeda Pharmaceuticals), a new formulation for the treatment of heartburn-associated gastroesophageal reflux disease (GERD) in adults age 18 and older.
Raised lesions of dysplatic Barrett's esophagus (BE) are treated with endoscopic mucosal resection (EMR) before ablation. But the procedure causes bleeding in 10% of cases.Mayo Clinic researchers said they found a way to reduce those adverse events.
The LINX Reflux Management System was recently shown to successfully control reflux-related symptoms in patients with gastroesophageal reflux disease (GERD), reducing their need to continue treatment with proton pump inhibitors (PPIs) and other acid-suppression medications.
Women giving birth through in-vitro fertilization (IVF) were reported more likely to experience the after-effects of long-term gastro-esophageal reflux disease (GERD) symptoms.
Research recently published in the Journal of Molecular Diagnostics reveals a new next-generation sequencing (NGS) test to detect genomic mutations in precarious esophageal tissue – potentially improving early detection in individuals with Barrett's esophagus (BE).
A study in JAMA Surgery identified several factors that cause a frequently used antireflux surgery to be unsuccessful.
A systematic review recently reported that antidepressants were beneficial for GERD patients – curbing esophageal sensation and reducing functional chest pain.
The treatment of gastrointestinal conditions requires not only physical attention, but, in some cases, addressing psychological concerns as well.

Most Popular


$vacMongoViewPlus$ $vAR$